Vulnerability in Linux Kernel
CVE-2026-24217
NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.008 (53.6th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 54th percentile — 53.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.008 · newest: 0.008 · change: 0.000
Affected products
Weakness classification (CWE)
References
- nvd.nist.gov/vuln/detail/CVE-2026-24217 (US Government Resource)
- www.cve.org/CVERecord (Third Party Advisory)
- nvidia.custhelp.com/app/answers/detail/a_id/5831 (Vendor Advisory)
Frequently asked questions
- What is CVE-2026-24217?
- CVE-2026-24217 is a high-severity vulnerability in Linux Kernel, classified under CWE-29. CVSS score: 8.8/10. Published 2026-05-20.
- How severe is CVE-2026-24217?
- High severity. CVSS v3 base score is 8.8 out of 10.